BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Tuesday, February 10, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Sep. 21, 2009
View Archived Issues
SK Chemicals to evaluate SID-530 and taxotere bioequivalence in a phase I trial
Read More
Novel MEK inhibitors in early development at UCB
Read More
New data on oseltamivir in H1N1 and H5N1 viruses discussed at ICAAC
Read More
In vitro, in vivo and phase I studies describe antibacterial ozenoxacin
Read More
Rib-X receives NIAID award to develop antibiotic treatment for gonorrhea
Read More
Arena reports BLOSSOM trial results for weight management
Read More
Vernalis completes recruitment in phase II V-3381 study for neuropathic pain
Read More
Zolinza approved in Canada for advanced cutaneous T-cell lymphoma
Read More
S1P1 receptor modulator BAF-312 developed as a potential new treatment for MS
Read More
Vitamin D3 analogue TEI-K04887 reduces PTH levels without causing hypercalcemia in vivo
Read More
MK-0674 reduces tumor-induced osteolysis in rabbit model of metastatic bone disease
Read More
OSI dislcoses novel protein kinase inhibitors for treating cancer
Read More
Neurogen describes novel TRPV1 modulators for the treatment of pain
Read More
New compounds for asthma therapy claimed by AstraZeneca and Argenta Discovery
Read More
Cel-Sci to begin clinical study of LEAPS-H1N1 in H1N1-infected patients
Read More
Hyperion receives orphan drug status for HPN-100 for hepatic encephalopathy
Read More
FDA Advisory Committee recommends Xiaflex approval for Dupuytren's disease
Read More
GSK provides update on pandemic (H1N1) influenza vaccine
Read More
Intarcia Therapeutics commences enrollment in phase II ITCA-650 study
Read More
KemPharm nominates candidate for treatment of pain
Read More
Sanofi-aventis receives FDA Complete Response Letter for eplivanserin
Read More
Savient provides update on meeting with FDA for Krystexxa
Read More
Pharmos reports results of phase IIb dextofisopam trial in irritable bowel syndrome
Read More
Biomoda adds longitudinal study to lung cancer phase II trial protocol
Read More
Companies validate cardiomyocyte progenitors derived from human embryonic stem cells
Read More
JTT-305 shows promise for the treatment of hypocalcemia and osteoporosis
Read More
